RobotLAB Expands “AI, Robotics & the Future of Work” Lineup
DALLAS--(BUSINESS WIRE)--Jul 6, 2023--
2023-07-07 05:59
Marketmind: Markets buckle under US rates, China blues
By Jamie McGeever A look at the day ahead in Asian markets from Jamie McGeever, financial markets columnist.
2023-07-07 05:58
Levi Lowers Full-Year Guidance on US Wholesale Weakness
Levi Strauss & Co. lowered its guidance for the full-year, citing weakness in its US wholesale business and
2023-07-07 05:56
Taylor Swift agreed to $100 million deal with FTX before it went bankrupt, but FTX pulled out
Taylor Swift signed onto a lucrative touring partnership with FTX before its collapse, but FTX pulled out of the arrangement, according to a person familiar with the discussions.
2023-07-07 05:53
Cierto Tequila Awarded Five Double Gold Medals at the 2023 Singapore World Spirits Competition
LOS ANGELES--(BUSINESS WIRE)--Jul 6, 2023--
2023-07-07 05:50
Birkenstock Owner Considers IPO at $6 Billion-Plus Value
L Catterton, the private equity firm backed by luxury French fashion house LVMH, is considering strategic options for
2023-07-07 05:46
BOJ Deputy Governor Uchida: Will maintain yield control to sustain easy policy
By Leika Kihara TOKYO Bank of Japan (BOJ) Deputy Governor Shinichi Uchida said the central bank will maintain
2023-07-07 05:45
Railroad industry sues to block limit on crew sizes that Ohio imposed after E. Palestine derailment
The railroad industry has sued to block a new minimum crew-size requirement that Ohio imposed after a fiery train derailment in East Palestine in February
2023-07-07 05:25
John Kerry to Visit China in Bid for Progress in Climate Crisis Talks
US Climate Envoy John Kerry is heading to China for talks on global warming as tensions simmer between
2023-07-07 05:22
AbbVie trims full-year profit forecast on higher R&D expenses
(Reuters) -AbbVie Inc cut its full-year profit forecast on Thursday, citing $280 million in milestone and in-process research and development
2023-07-07 05:20
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to
2023-07-07 05:16
L Catterton considering IPO for Birkenstock at $6 billion- Bloomberg News
L Catterton, a private equity firm backed by LVMH, is considering strategic options for Birkenstock including an initial
2023-07-07 05:15
You Might Like...
Bezos' Blue Origin sees third executive departure amid internal restructuring
Millennials and Gen Z Consumers Believe Current Economic Environment Is Hurting Their Ability to Be Financially Independent Adults
ECB Quarter-Point Quandary Keeps Market on Tenterhooks
Venezuela torture victim uses VR to shed light on infamous prison
European shares edge higher at open, defensive healthcare stocks up
Israel's Economy Set to Shrink 11% as Hamas War Escalates: JPMorgan
EU Aims to Unveil Plan to Tap Frozen Russian Assets Amid Doubts
HSBC Targets ‘Mid-Teens’ Asia Returns Amid Ping An Pressure